In this weeks video, Dr. Brian G.M. Durie defines minimal residual disease (MRD) and explains how MRD-testing can be used for ongoing monitoring.
BOTTOM LINE:
?As it may one day be a guide for assessing treatment outcomes, myeloma patients should familiarize themselves with MRD-testing.